NO20043371L - Kortikotropinfrigjorendefaktorreseptor-2 agonister - Google Patents

Kortikotropinfrigjorendefaktorreseptor-2 agonister

Info

Publication number
NO20043371L
NO20043371L NO20043371A NO20043371A NO20043371L NO 20043371 L NO20043371 L NO 20043371L NO 20043371 A NO20043371 A NO 20043371A NO 20043371 A NO20043371 A NO 20043371A NO 20043371 L NO20043371 L NO 20043371L
Authority
NO
Norway
Prior art keywords
corticotropin
releasing factor
agonists
factor receptor
receptors
Prior art date
Application number
NO20043371A
Other languages
English (en)
Inventor
Robert Joseph Isfort
Adam Wieslaw Mazur
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20043371L publication Critical patent/NO20043371L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Isolerte derivater av den kortikotropinfrigj ørende faktor, og nukleinsyrer som koder disse, er effektive for å behandle forstyrrelser, så som muskeldystrofi, som modulereres av reseptorer av den kortikotropinfrigj ørende faktor 2.
NO20043371A 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister NO20043371L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19
PCT/US2003/001451 WO2003062268A2 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number Publication Date
NO20043371L true NO20043371L (no) 2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043371A NO20043371L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Country Status (29)

Country Link
US (7) US7192923B2 (no)
EP (4) EP1465923B1 (no)
JP (3) JP4508648B2 (no)
KR (3) KR100758857B1 (no)
CN (3) CN100475844C (no)
AR (3) AR038142A1 (no)
AT (4) ATE383372T1 (no)
AU (2) AU2003205197B2 (no)
BR (3) BR0306826A (no)
CA (3) CA2470731C (no)
CY (1) CY1106133T1 (no)
DE (4) DE60313845T2 (no)
DK (2) DK1465921T3 (no)
ES (4) ES2269976T3 (no)
IL (5) IL162530A0 (no)
MA (3) MA27590A1 (no)
MX (3) MXPA04006884A (no)
MY (1) MY140306A (no)
NO (3) NO20043366L (no)
NZ (3) NZ533600A (no)
PE (3) PE20030974A1 (no)
PL (3) PL371364A1 (no)
PT (2) PT1465923E (no)
RU (1) RU2294333C2 (no)
SA (3) SA03230564A (no)
SI (1) SI1465921T1 (no)
TW (3) TW200302278A (no)
WO (3) WO2003062268A2 (no)
ZA (1) ZA200404995B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2427490A1 (en) * 2000-09-22 2002-03-28 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US7192923B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
BRPI0609460A2 (pt) * 2005-03-30 2010-04-13 Novartis Vaccines & Diagnostics Inc haemophilus influenzae tipo b
WO2007090087A2 (en) * 2006-01-27 2007-08-09 Research Development Foundation Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
KR20100056507A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ｐｒｏ－ｇｌｙ－ｔｈｒ－ｃｙｓ－ｇｌｕ－ｉｌｅ－ｃｙｓ－ａｌａ－ｔｙｒ－ａｌａ－ａｌａ－ｃｙｓ－ｔｈｒ－ｇｌｙ－ｃｙｓ의 용도
AU2008297874A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of secretin and optionally urodilatin as therapeutic agents
JP2012508014A (ja) * 2008-11-04 2012-04-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃｒｈｒ２ペプチド作動薬及びその使用
EP2206726A1 (en) * 2009-01-08 2010-07-14 Universite Joseph Fourier Non-invasive tools for detecting vulnerable atherosclerotic plaques
PH12012500895A1 (en) * 2009-11-04 2012-11-12 Janssen Pharmaceutica Nv Method for treating heart failure with stresscopin-like peptides
WO2013063046A1 (en) 2011-10-24 2013-05-02 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
JP6562632B2 (ja) 2012-02-14 2019-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現
JOP20170153A1 (ar) * 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
CA3040889A1 (en) * 2016-10-20 2018-04-26 Cortene Inc. Methods of treating diseases resulting from a maladapted stress response
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途
WO2025184558A1 (en) * 2024-02-28 2025-09-04 Caradon Therapeutics, Inc. Modified urocortin 3
WO2025222010A1 (en) * 2024-04-19 2025-10-23 Neurocrine Biosciences, Inc. Corticotropin releasing factor receptor 2 (crfr2) agonists
AU2025204485B2 (en) * 2024-04-30 2025-12-11 Hanmi Pharm. Co. Ltd. Use of crf2 receptor agonist and the acylated conjugates thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
EP0860501A3 (en) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin-releasing factor2 receptors
US5786203A (en) * 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US5663292A (en) * 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
EP0845035A2 (en) 1995-06-13 1998-06-03 The Salk Institute For Biological Studies Urocortin peptides
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
IL154102A0 (en) 2000-08-04 2003-07-31 Res Dev Foundation Urocortin proteins and uses thereof
CA2427490A1 (en) * 2000-09-22 2002-03-28 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7192923B2 (en) 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
CA2470656C (en) 2011-06-28
KR20040082390A (ko) 2004-09-24
EP1465923B1 (en) 2007-05-16
WO2003062268A2 (en) 2003-07-31
JP4489434B2 (ja) 2010-06-23
DE60307044T2 (de) 2007-02-15
MA27590A1 (fr) 2005-11-01
CA2470731C (en) 2011-06-21
JP2005525101A (ja) 2005-08-25
MY140306A (en) 2009-12-31
ES2309909T3 (es) 2008-12-16
US20060025339A1 (en) 2006-02-02
CN1617887A (zh) 2005-05-18
IL162530A0 (en) 2005-11-20
BR0306826A (pt) 2005-09-06
PL373139A1 (en) 2005-08-22
AR038143A1 (es) 2004-12-29
MXPA04006883A (es) 2004-12-06
AR038144A1 (es) 2004-12-29
IL197774A0 (en) 2009-12-24
PE20030747A1 (es) 2003-10-23
KR20040082389A (ko) 2004-09-24
BR0306878A (pt) 2004-10-26
WO2003062268A3 (en) 2003-11-27
MA27591A1 (fr) 2005-11-01
SA03230565A (ar) 2005-12-03
ES2287484T3 (es) 2007-12-16
US20090124793A1 (en) 2009-05-14
EP1724283B1 (en) 2008-06-18
JP4508649B2 (ja) 2010-07-21
SA03230564A (ar) 2005-12-03
NZ533599A (en) 2007-03-30
ATE334147T1 (de) 2006-08-15
DE60318547T2 (de) 2008-12-24
DK1465921T3 (da) 2006-11-27
PT1465923E (pt) 2007-08-06
ATE383372T1 (de) 2008-01-15
ES2269976T3 (es) 2007-04-01
US7632933B2 (en) 2009-12-15
IL162529A0 (en) 2005-11-20
SA03230565B1 (ar) 2006-10-31
IL162431A0 (en) 2005-11-20
CA2470743C (en) 2011-12-13
PT1465921E (pt) 2006-12-29
AR038142A1 (es) 2004-12-29
US20100197579A1 (en) 2010-08-05
MA27592A1 (fr) 2005-11-01
DK1465923T3 (da) 2007-07-02
EP1724283A2 (en) 2006-11-22
RU2294333C2 (ru) 2007-02-27
US7192923B2 (en) 2007-03-20
TW200302278A (en) 2003-08-01
DE60307044D1 (de) 2006-09-07
SA03230564B1 (ar) 2006-10-31
KR100758857B1 (ko) 2007-09-14
MXPA04006885A (es) 2004-12-06
NZ533600A (en) 2007-02-23
CA2470743A1 (en) 2003-07-31
CA2470656A1 (en) 2003-07-31
EP1724283A3 (en) 2007-04-11
CN1617885A (zh) 2005-05-18
DE60318547D1 (de) 2008-02-21
PL373529A1 (en) 2005-09-05
US7192924B2 (en) 2007-03-20
EP1465922B1 (en) 2008-01-09
ZA200404995B (en) 2005-06-29
DE60313845T2 (de) 2008-01-31
TWI300442B (en) 2008-09-01
NO20043396L (no) 2004-10-06
SI1465921T1 (sl) 2006-10-31
CN1617886A (zh) 2005-05-18
PE20030974A1 (es) 2003-12-26
MXPA04006884A (es) 2004-12-06
AU2003205197B2 (en) 2006-03-02
TW200302277A (en) 2003-08-01
EP1465921B1 (en) 2006-07-26
RU2004124847A (ru) 2005-04-20
DE60313845D1 (de) 2007-06-28
CY1106133T1 (el) 2011-06-08
NO20043366L (no) 2004-10-06
BR0306838A (pt) 2005-04-05
PE20030849A1 (es) 2003-12-01
CA2470731A1 (en) 2003-07-31
KR100735586B1 (ko) 2007-07-04
US20080004435A1 (en) 2008-01-03
JP4508648B2 (ja) 2010-07-21
IL196384A0 (en) 2011-07-31
US6936585B2 (en) 2005-08-30
US7897731B2 (en) 2011-03-01
WO2003062277A1 (en) 2003-07-31
JP2005521387A (ja) 2005-07-21
NZ533598A (en) 2007-03-30
US20030148957A1 (en) 2003-08-07
EP1465923A1 (en) 2004-10-13
EP1465922A2 (en) 2004-10-13
DE60321730D1 (de) 2008-07-31
US20030148958A1 (en) 2003-08-07
TW200302276A (en) 2003-08-01
KR20040082392A (ko) 2004-09-24
CN100391972C (zh) 2008-06-04
US7608701B2 (en) 2009-10-27
JP2005522191A (ja) 2005-07-28
US20030148956A1 (en) 2003-08-07
AU2003237419B2 (en) 2006-04-13
KR100758858B1 (ko) 2007-09-14
WO2003062269A3 (en) 2003-11-06
EP1465921A2 (en) 2004-10-13
CN100475844C (zh) 2009-04-08
WO2003062269A2 (en) 2003-07-31
ATE362488T1 (de) 2007-06-15
ES2299701T3 (es) 2008-06-01
ATE398632T1 (de) 2008-07-15
PL371364A1 (en) 2005-06-13
HK1078095A1 (zh) 2006-03-03
US7462597B2 (en) 2008-12-09

Similar Documents

Publication Publication Date Title
NO20043371L (no) Kortikotropinfrigjorendefaktorreseptor-2 agonister
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
DE602004016158D1 (de) 3-substituierte 5,6-diaryl-pyrazin-2-carbonsäureamid- und -2-sulfonsäureamidderivative als cb1 modulatoren
WO2005005462A3 (en) Blys antagonists and uses thereof
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
AU2002340010A1 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
WO2004022714A3 (en) Organic species that facilitate charge transfer to or from nanostructures
ATE533365T1 (de) Herabsetzung von tabakbestandteilen
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
NO20091976L (no) Nye forbindelser
DK1458713T3 (da) Indolinonderivater anvendelige som proteinkinaseinhibitorer
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
NO20071378L (no) Tiazolo-naftylsyrer.
GB0327380D0 (en) Method
NO20045025L (no) Nye forbindelser
NO20082849L (no) Behandlingsfluid for underjordisk formasjon omfattende zeolitt samt fremgangsmate ved behandling av en underjordisk formasjon
NO20074805L (no) Fremgangsmate for a identifisere PDE11-modulatorer
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
ATE441642T1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
CY1105345T1 (el) Φαινυλαλκινια

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application